BACKGROUND: Patient-centered health care interventions, such as heart failure disease management programs, are under increasing pressure to demonstrate good value. Variability in costing methods and assumptions in economic evaluations of such interventions limit the comparability of cost estimates across studies. Valid cost estimation is critical to conducting economic evaluations and for program budgeting and reimbursement negotiations. METHODS AND RESULTS: Using sound economic principles, we developed the Tools for Economic Analysis of Patient Management Interventions in Heart Failure (TEAM-HF) Costing Tool, a spreadsheet program that can be used by researchers and health care managers to systematically generate cost estimates for economic evaluations and to inform budgetary decisions. The tool guides users on data collection and cost assignment for associated personnel, facilities, equipment, supplies, patient incentives, miscellaneous items, and start-up activities. The tool generates estimates of total program costs, cost per patient, and cost per week and presents results using both standardized and customized unit costs for side-by-side comparisons. Results from pilot testing indicated that the tool was well-formatted, easy to use, and followed a logical order. Cost estimates of a 12-week exercise training program in patients with heart failure were generated with the costing tool and were found to be consistent with estimates published in a recent study. CONCLUSIONS: The TEAM-HF Costing Tool could prove to be a valuable resource for researchers and health care managers to generate comprehensive cost estimates of patient-centered interventions in heart failure or other conditions for conducting high-quality economic evaluations and making well-informed health care management decisions.
BACKGROUND:Patient-centered health care interventions, such as heart failure disease management programs, are under increasing pressure to demonstrate good value. Variability in costing methods and assumptions in economic evaluations of such interventions limit the comparability of cost estimates across studies. Valid cost estimation is critical to conducting economic evaluations and for program budgeting and reimbursement negotiations. METHODS AND RESULTS: Using sound economic principles, we developed the Tools for Economic Analysis of Patient Management Interventions in Heart Failure (TEAM-HF) Costing Tool, a spreadsheet program that can be used by researchers and health care managers to systematically generate cost estimates for economic evaluations and to inform budgetary decisions. The tool guides users on data collection and cost assignment for associated personnel, facilities, equipment, supplies, patient incentives, miscellaneous items, and start-up activities. The tool generates estimates of total program costs, cost per patient, and cost per week and presents results using both standardized and customized unit costs for side-by-side comparisons. Results from pilot testing indicated that the tool was well-formatted, easy to use, and followed a logical order. Cost estimates of a 12-week exercise training program in patients with heart failure were generated with the costing tool and were found to be consistent with estimates published in a recent study. CONCLUSIONS: The TEAM-HF Costing Tool could prove to be a valuable resource for researchers and health care managers to generate comprehensive cost estimates of patient-centered interventions in heart failure or other conditions for conducting high-quality economic evaluations and making well-informed health care management decisions.
Authors: Harlan M Krumholz; Joan Amatruda; Grace L Smith; Jennifer A Mattera; Sarah A Roumanis; Martha J Radford; Paula Crombie; Viola Vaccarino Journal: J Am Coll Cardiol Date: 2002-01-02 Impact factor: 24.094
Authors: Shelby D Reed; David J Whellan; Yanhong Li; Joëlle Y Friedman; Stephen J Ellis; Ileana L Piña; Sharon J Settles; Linda Davidson-Ray; Johanna L Johnson; Lawton S Cooper; Christopher M O'Connor; Kevin A Schulman Journal: Circ Cardiovasc Qual Outcomes Date: 2010-06-15
Authors: Shelby D Reed; Yanhong Li; Eugene Z Oddone; Alice M Neary; Melinda M Orr; Janet M Grubber; Felicia L Graham; Maren K Olsen; Laura P Svetkey; Rowena J Dolor; Benjamin J Powers; Martha B Adams; Hayden B Bosworth Journal: Am J Hypertens Date: 2009-11-19 Impact factor: 2.689
Authors: Gordon R Reeves; David J Whellan; Pamela Duncan; Christopher M O'Connor; Amy M Pastva; Joel D Eggebeen; Leigh Ann Hewston; Timothy M Morgan; Shelby D Reed; W Jack Rejeski; Robert J Mentz; Paul B Rosenberg; Dalane W Kitzman Journal: Am Heart J Date: 2016-12-28 Impact factor: 4.749
Authors: Sarah A Kelleher; Caroline S Dorfman; Jen C Plumb Vilardaga; Catherine Majestic; Joseph Winger; Vicky Gandhi; Christine Nunez; Alyssa Van Denburg; Rebecca A Shelby; Shelby D Reed; Susan Murphy; Marie Davidian; Eric B Laber; Gretchen G Kimmick; Kelly W Westbrook; Amy P Abernethy; Tamara J Somers Journal: Contemp Clin Trials Date: 2017-04-11 Impact factor: 2.226
Authors: Corrine I Voils; Erica Levine; Jennifer M Gierisch; Jane Pendergast; Sarah L Hale; Megan A McVay; Shelby D Reed; William S Yancy; Gary Bennett; Elizabeth M Strawbridge; Allison C White; Ryan J Shaw Journal: Contemp Clin Trials Date: 2017-12-28 Impact factor: 2.226
Authors: Rebecca A Shelby; Caroline S Dorfman; Hayden B Bosworth; Francis Keefe; Linda Sutton; Lynda Owen; Leonor Corsino; Alaattin Erkanli; Shelby D Reed; Sarah S Arthur; Tamara Somers; Nadine Barrett; Scott Huettel; Juan Marcos Gonzalez; Gretchen Kimmick Journal: Contemp Clin Trials Date: 2018-11-22 Impact factor: 2.226
Authors: Shelby D Reed; Matthew P Neilson; Matthew Gardner; Yanhong Li; Andrew H Briggs; Daniel E Polsky; Felicia L Graham; Margaret T Bowers; Sara C Paul; Bradi B Granger; Kevin A Schulman; David J Whellan; Barbara Riegel; Wayne C Levy Journal: Am Heart J Date: 2015-08-20 Impact factor: 4.749
Authors: Amer I Aladin; David Whellan; Robert J Mentz; Amy M Pastva; M Benjamin Nelson; Peter Brubaker; Pamela Duncan; Gordon Reeves; Paul Rosenberg; Dalane W Kitzman Journal: J Am Geriatr Soc Date: 2021-04-10 Impact factor: 7.538
Authors: Daniel L Riddle; Francis J Keefe; Dennis Ang; Khaled J; Levent Dumenci; Mark P Jensen; Matthew J Bair; Shelby D Reed; Kurt Kroenke Journal: BMC Musculoskelet Disord Date: 2012-08-20 Impact factor: 2.362